Versican, a proteoglycan with pivotal roles in cellular dynamics, undergoes intricate regulation by a diverse array of chemical activators. These compounds, each wielding a specific biochemical prowess, orchestrate a symphony of molecular events culminating in the activation of Versican. Retinoic acid, a derivative of vitamin A, indirectly influences Versican through the RAR/RXR signaling pathway, showcasing the intricacies of transcriptional control. Meanwhile, N-Acetylcysteine, a thiol compound, exerts its effects by enhancing cellular redox balance, thereby indirectly impacting Versican through the modulation of oxidative stress-responsive pathways. The indirect activation of Versican is further exemplified by Lithium Chloride, a regulator of the Wnt/β-catenin pathway. Lithium's inhibition of GSK-3β results in the stabilization of β-catenin, influencing Versican expression and contributing to cellular dynamics. This chemical dance extends to Y-27632, a selective ROCK inhibitor, affecting Versican through cytoskeletal organization alterations. These indirect activators exemplify the complexity of Versican regulation, as seen in the epigenetic modulation induced by 5-Azacytidine, a DNA methyltransferase inhibitor, altering gene promoters and influencing Versican expression. SB-431542 disrupts TGF-β signaling, revealing the crosstalk between TGF-β signaling and Versican regulation.
Histone deacetylase inhibitor Trichostatin A, PI3K inhibitor Wortmannin, and short-chain fatty acid Butyrate showcase the role of epigenetics and signaling pathways in Versican modulation. Piceatannol, a natural stilbene, and U0126, a MEK1/2 inhibitor, exemplify the impact of pathway-specific interventions, influencing Versican through JAK/STAT and MAPK/ERK signaling, respectively. Lastly, Nordihydroguaiaretic Acid (NDGA), a lipoxygenase inhibitor, introduces the modulation of arachidonic acid metabolism into the molecular repertoire, emphasizing the diverse strategies employed by Versican activators. In this intricate molecular ballet, each chemical fulfills a unique role, highlighting the versatility of Versican regulation in cellular contexts.
SEE ALSO...
Items 11 to 14 of 14 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Butyric acid | 107-92-6 | sc-214640 sc-214640A | 1 kg 10 kg | $64.00 $177.00 | ||
Butyrate, a short-chain fatty acid, indirectly activates Versican through epigenetic modifications. Acting as a histone deacetylase inhibitor, Butyrate influences chromatin structure, leading to altered gene expression, including enhanced transcription of Versican and its regulatory elements. | ||||||
Piceatannol | 10083-24-6 | sc-200610 sc-200610A sc-200610B | 1 mg 5 mg 25 mg | $51.00 $71.00 $199.00 | 11 | |
Piceatannol, a natural stilbene, indirectly activates Versican through inhibition of the JAK/STAT pathway. By targeting JAK kinases, Piceatannol disrupts STAT signaling, influencing the transcriptional regulation of Versican and contributing to its modulation in diverse cellular contexts. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
LPA is a bioactive lipid that indirectly influences versican expression. It activates LPA receptors, initiating signaling cascades that can impact versican transcription and synthesis. The LPA-mediated pathway contributes to the regulation of versican levels, influencing extracellular matrix dynamics and cellular responses associated with versican, such as cell adhesion and migration. | ||||||
NDGA (Nordihydroguaiaretic acid) | 500-38-9 | sc-200487 sc-200487A sc-200487B | 1 g 5 g 25 g | $109.00 $384.00 $2190.00 | 3 | |
Nordihydroguaiaretic acid (NDGA), a lipoxygenase inhibitor, indirectly activates Versican by influencing arachidonic acid metabolism. By inhibiting lipoxygenases, NDGA alters lipid mediator production, affecting signaling pathways that regulate Versican expression and contribute to cellular dynamics. | ||||||